Merck hires JPMorgan for asset sale

German chemicals and pharmaceuticals company Merck is looking to exit the highly-competitive biosimilars business after hiring JPMorgan to explore the sale of its US$1bn unit. Biosimilars, the biotechnology-based equivalents of…